Langerhans cell histiocytosis of the temporal bones: a clinical case

DOI: https://doi.org/10.29296/25877305-2022-01-13
Issue: 
1
Year: 
2022

Professor Kh. Diab, MD; Corresponding Member of the Russian Academy of Sciences, Professor N.
Daikhes, MD; V. Saidulaev, Candidate of Medical Sciences; Professor A. Yunusov, MD; O. Pashinina, Candidate
of Medical Sciences; A. Mikhalevich, Candidate of Medical Sciences National Medical Research Center of
Otorhinolaryngology, Federal Biomedical Agency of Russia, Moscow

Langerhans cell histiocytosis (LCH) is a rare disease with an incidence of 1 to 9 cases per 1,000,000 population per year. From 75 to 90% of cases of the disease occur in childhood. The etiology of the disease is unknown. Pathogenetically, the disease is characterized by a clonal proliferation of Langerhans cells – the lymphoid dendritic cells originating from the bone marrow have an antigen-presenting function outside the dermis. The temporal bones are affected in 25-30% of cases. The disease is more common in males. The peak incidence occurs in the first 3 years of life. The disease can be asymptomatic for a long time or be masked as other common middle ear pathologies (chronic suppurative otitis media, mastoiditis, and otitis externa). The article describes a clinical case of temporal bone LCH. The feature of the clinical case in the recurrent course of the disease is that it is masked as acute mastoiditis.
Keywords: 
orphan diseases
Langerhans cell histiocytosis
temporal bone
computed tomography

References: 
  1. Dolgov V.A., Anikin M.I., Gorbaneva G.A. i dr. Sluchaj obnaruzhenija gistiotsitoza u grudnogo rebenka, pervonachal'no diagnostiruemogo kak seroznoe vospalenie srednego uha. Rossijskaja otorinolaringologija. 2016; 1: 112–5 [Dolgov V.A., Anikin M.I., Gorbaneva G.A. et al. The case of detection of histiocytosis in nursing infant primarily diagnosed as serous inflammation of middle ear. Rossiiskaya otorinolaringologiya. 2016; 1: 112–5 (in Russ.)]. DOI: 10.18692/1810-4800-2016-1-112-115.
  2. Lazjuk I.I., Borisevich G.A., Sergeeva A.A. i dr. K voprosu diagnostiki gistiotsitoza iz kletok Langergarsa. Novosti luchevoj diagnostiki. 1998; 4: 13–5 [Lazyuk I.I., Borisevich G.A., Sergeeva A.A. i dr. K voprosu diagnostiki gistiotsitoza iz kletok Langergarsa. Novosti luchevoi diagnostiki. 1998; 4: 13–5 (in Russ.)]. URL: https://radiomed.ru/publications/obz-gistiotsitoz-k-voprosu-diagnostiki-gistiotsitoza-iz-kletok-langergarsa
  3. Blumberg J.M., Malhotra A., Wu X. et al. Langerhans Cell Histiocytosis of the Temporal Bone with Otic Capsule Involvement. Clin Neuroradiol. 2017; 27 (2): 163–8. DOI: 10.1007/s00062-015-0461-4
  4. Hussein Algahtani, Bader Shirah, Mohammed Bajunaid et al. Clinicoradiological Discrepancy in Multisystem Langerhans Cell Histiocytosis with Central Nervous System Involvement. Gulf J Oncolog. 2019; 1 (31): 72–7.
  5. Broadbent V., Egeler R.M., Nesbit M.E. et al Langerhans cell histiocytosis – clinical and epidemiological aspects. Br J Cancer. 1994; 23 (1): 11–6.
  6. Guyot-Goubin A., Donadieu J., Barkaoui M. Descriptive epidemiology of childhood Langerhans cell histiocytosis in France, 2000–2004. Pediatr Blood Cancer. 2008; 51: 71–5. DOI: 10.1002/pbc.21498
  7. Dajhes N.A., Diab H.M., Zagorskaja D.A. i dr. Gistiotsitoz kletok Langergansa visochnoj kosti. Annaly hirurgii. 2018; 23 (2): 121–6 [Daykhes N.A., Diab Kh.M., Zagorskaya D.A. et al. Langerhans cell histiocytosis of the temporal bone. Annaly Khirurgii = Russian Journal of Surgery. 2018; 23 (2): 121–6 (in Russ.)]. DOI: 10.18821/1560-9502-2018-23-2-121-126.
  8. Campos M.K., Viana M.B., de Oliveira B.M. et al. Langerhans cell histiocytosis: a 16-year experience. J Pediatr. (Rio J.). 2007; 83 (1): 79–86. DOI: 10.2223/JPED.1581
  9. Boston M., Derkay C.S. Langerhans’ cell histiocytosis of the temporal bone and skull base. Am J Otolaryngol. 2002; 23: 246–8. DOI: 10.1053/ajot.2002.123452
  10. Monsereenusorn C., Rodriguez-Galindo C. Clinical characteristics and treatment of langerhans cell histiocytosis. Hematol Oncol Clin North Am. 2015; 29 (5): 853–73. DOI: 10.1016/j.hoc.2015.06.005
  11. Stull M.A., Kransdorf M.J., Devaney K.O. Langerhans cell histiocytosis of bone. Radiographics. 1992; 12 (4): 801–23. DOI: 10.1148/radiographics.12.4.1636041
  12. Stalemark H., Laurencikas E., Karis J. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008; 51: 76–81. DOI: 10.1002/pbc.21504
  13. Salotti J.A., Nanduri V., Pearce M.S. Incidence and clinical features of Langerhans cell histiocytosis in the UK and Ireland. Arch Dis Child. 2009; 94: 376–80. DOI: 10.1136/adc.2008.144527
  14. D’Ambrosio N., Soohoo S., Warshall C. et al. Craniofacial and intracranial manifestations of Langerhans cell histiocytosis: report of findings in 100 cases. Am J Roentgenol. 2008; 191: 589–97. DOI: 10.2214/AJR.07.3573
  15. Majumder A., Wick C.C., Collins R. et al. Pediatric Langerhans cell histiocytosis of the lateral skull base. Int J Pediatr Otorhinolaryngol. 2017; 99: 135–40. DOI: 10.1016/j.ijporl.2017.06.011
  16. Cochrane L.A., Prince M., Clarke K. Langerhans’ cell histiocytosis in the paediatric population: presentation and treatment of head and neck manifestations. J Otolaryngol. 2003; 32: 33–7. DOI: 10.2310/7070.2003.35266
  17. DiNardo L.J., Wetmore R.F. Head and neck manifestations of histiocytosis-X in children. Laryngoscope. 1989; 99: 721–4. DOI: 10.1288/00005537-198907000-00011
  18. Irving R.M., Broadbent V., Jones N.S. Langerhans’ cell histiocytosis in childhood: Management of head and neck manifestations. Laryngoscope. 1994; 104: 64–70. DOI: 10.1288/00005537-199401000-00011
  19. Vezina J.-P., Audet N., Fradet G. Cerebrospinal fluid otorrhoea: a rare presentation of Langerhans’ cell histiocytosis of the temporal bone. J Laryngol Otol. 2010; 124 (5): 545–8. DOI: 10.1017/S0022215109992295